ASTM Stock News 3.91 05/13/2014 18:49:47 Aastrom Biosciences

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aastrom Biosciences (ASTM) 3.91 $ASTM

RadNet (RDNT) Surges: Stock Moves 21.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:21AM CDT
RadNet, Inc. (RDNT) was a big mover last session, as the company saw its shares rise by almost 22% on the day.

Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014
GlobeNewswire - Fri May 09, 3:05PM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following webcast:

Aastrom to Hold Annual Meeting of Shareholders on May 7, 2014
GlobeNewswire - Fri May 02, 3:05PM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that the company will hold its annual shareholders meeting on May 7, 2014 at 9:00 a.m. (EDT) at the company headquarters in Ann Arbor, Michigan. Shareholders of record as of March 11, 2014 are entitled to notice of and to vote at the meeting.

Prothena Corporation plc (PRTA) Worth Watching: Stock Rises 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:44AM CDT
Prothena Corporation plc (PRTA) was a big mover last session, as the company saw its shares rally nearly 10.00% on the day.

Upcoming Conference Calls, Commencement of Shipments, Stock Price Movements, Awareness Campaigns, and Acquisitions - Analyst Notes on Incyte, Impax, ANI, Ironwood and Aastrom
PR Newswire - Thu Apr 24, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Incyte Corporation (NASDAQ: INCY), Impax Laboratories Inc. (NASDAQ: IPXL), ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) and Aastrom Biosciences, Inc. (NASDAQ: ASTM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1519-100free.

Centene (CNC) Soars: Stock Adds 12.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:57AM CDT
Centene Corp. (CNC) was a big mover last session, as the company saw its shares rise over 12% on the day.

Allergan Inc. (AGN) in Focus: Stock Rallies 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:44AM CDT
Allergan Inc. was a big mover last session, as the company saw its shares surge over 15.0% on the day.

ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 7:44AM CDT
ANI Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares surge nearly 21% on the day.

Aastrom to buy USD6.5m Cell Therapy and Regenerative Medicine business from Sanofi
M2 - Tue Apr 22, 6:12AM CDT
Nulticellular therapies company Aastrom Biosciences (NasdaqCM:ASTM) revealed on Monday the launch of a definitive agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine (CTRM) business for a purchase price of USD6.5m in cash in promissory note.

Why Aastrom Biosciences (ASTM) Stock Is Soaring Today
at The Street - Mon Apr 21, 10:22AM CDT
Aastrom Biosciences (ASTM) soared Monday after the company announced its acquisition of Sanofi's Cell Therapy and Regenerative Medicine, or CTRM, business for $6.5 million. Aastrom will pay $4 million in cash and $2.5 million in a promissory note for...

Traders Get Bullish on Shares of Aastrom Biosciences, Shares Up 28.4% (ASTM)
Comtex SmarTrend(R) - Mon Apr 21, 10:10AM CDT
Aastrom Biosciences (NASDAQ:ASTM) is one of today's best performing low-priced stocks, up 28.4% to $4.52 on 2.4x average daily volume. Thus far today, Aastrom Biosciences has traded 1.6 million shares, vs. average volume of 683,000 shares per day. The stock has outperformed the Dow (28.4% to the Dow's 0.0%) and outperformed the S&P 500 (28.4% to the S&P's 0.0%) during today's trading.

Strength Seen in Retrophin, Inc. (RTRX) as Stock Shoots up 18% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 7:44AM CDT
Retrophin, Inc. was a big mover last session, as the company saw its shares surge ahead 18% on the day.

Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business
GlobeNewswire - Mon Apr 21, 7:39AM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that it has entered into a definitive agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine (CTRM) business for a purchase price of $6.5 million, with $4 million payable in cash at closing and $2.5 million payable in the form of a promissory note. The acquisition is subject to customary closing conditions and is scheduled to close in approximately three weeks.

ImmunoGen, Inc. (IMGN) in Focus: Stock Rallies 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 7:44AM CDT
ImmunoGen, Inc. was a big mover last session, as the company saw its shares surge 11% on the day.

Kythera Biopharmaceuticals, Inc. (KYTH) in Focus: Stock Surges 9.9 % - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 7:44AM CDT
Kythera Biopharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 10% on the day.

Technical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte, Merrimack Pharma, and Aastrom Biosciences
PR Newswire - Mon Apr 14, 8:00AM CDT
On Friday, April 11, 2014, the NASDAQ Composite ended at 3,999.73, down 1.34%, the Dow Jones Industrial Average declined 0.89% to 16,026.75, and the S&P 500 closed at 1,815.69, down 0.95%. The losses were broad based as all the 10 sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has lost 4.46% in the last one month. Investor-Edge has initiated coverage on the following equities: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Incyte Corp. Ltd (NASDAQ: INCY), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) and Aastrom Biosciences Inc. (NASDAQ: ASTM). Free technical research on ALXN, INCY, MACK and ASTM can be downloaded upon signing up at:

Baxano Surgical, Inc. (BAXS) in Focus: Stock up 10.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 7:44AM CDT
Baxano Surgical, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day.

Enzymotec Ltd. (ENZY) in Focus: Stock Rallies 11.06% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:44AM CDT
Enzymotec Ltd. was a big mover last session, as the company saw its shares rise a little over 11% on the day.

Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial
GlobeNewswire - Wed Apr 09, 8:22AM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that the independent Data and Safety Monitoring Board (DSMB) for the company's ixCELL-DCM Phase 2b clinical trial has recommended continuing the study without modification as planned following an interim review of unblinded safety data from the trial.

RadNet, Inc. (RDNT) in Focus: Stock Surges 9.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 7:44AM CDT
RadNet, Inc. was a big mover last session, as the company saw its shares rise nearly 10% on the day.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 89

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
Yoodli's No. 9 Ranking Signals Enterprise AI Traction

Updated Category News Views 96

Ninth place can be easy to dismiss until you notice the company is sitting near the top of a 500-name growth list. Yoodli's No. 9 position on Deloitte's 2026 Technology Fast 500 is a meaningful signal that its AI-based coaching and workforce-skills pitch is getting traction inside large organizations. It is not a revenue disclosure, it is not a valuation marker, and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 161

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 114

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading
The Hanover Survey Puts Small-Business Trust on Trial

Updated Category News Views 91

A dark storefront can apparently erase goodwill faster than plenty of owners want to admit. The Hanover Insurance Group's 2026 Small Business Pulse Report found that 60% of surveyed consumers would temporarily buy from a competitor if their preferred small business shut unexpectedly. More than half would start looking elsewhere within a week. That is not a cute...

Continue Reading
Peñoles Locks In Solar Storage for Northern Mine Loads

Updated Category News Views 45

A mine never sleeps, which is why the battery matters more than the solar-panel headline. Peñoles has signed a 20-year power-supply agreement with Atlas Renewable Energy for a Coahuila project combining 269 MWp of solar generation with battery storage. The project is slated to begin operating in the first half of 2029 and is expected to provide roughly 550 GWh a year to...

Continue Reading
Norfolk Southern's 200-Year Campaign Meets a Hard Market

Updated Category News Views 61

Two centuries of railroad history can stir the blood, but it does not move a single carload by itself. Norfolk Southern has opened its 200-year railroading celebration with the GeneratioNS campaign, a three-locomotive NS 200 commemorative series, and plans for public events across its network. For a railroad with deep roots and very modern operational pressures, this is...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 157

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading

Top 5 Most Recently Viewed Articles

evolv Consulting and Snowflake Join Forces in Automotive Tech

Updated Category News Views 205

evolv Consulting Partners with Snowflake for Automotive Innovation evolv Consulting empowers data-driven insights at scale for the automotive industry through Snowflake AI Data Cloud for Manufacturing. evolv Consulting, recognized as an Elite Snowflake Services partner, has announced a strategic collaboration with Snowflake to enhance the AI Data Cloud for Manufacturing...

Continue Reading
Martela Corporation Shares Decline: Key Updates and Implications

Updated Category News Views 158

Martela Corporation Reports Notable Changes in Shareholding Martela Corporation has recently seen significant transactions that impact its share structure, which is crucial information for investors. On a particular date, Isku-Yhtymä Oy made an important announcement regarding its shareholding in Martela. This report revealed that Isku-Yhtymä Oy had sold enough shares...

Continue Reading
Forecasting Growth in the Chlorine Trifluoride Market by 2032

Updated Category News Views 221

Overview of the Chlorine Trifluoride Market Chlorine trifluoride is emerging as a pivotal player in numerous high-tech applications, with the market anticipated to reach a staggering USD 82.81 million by 2032. This significant growth is fueled by an annual compound growth rate (CAGR) of 4.64% from the previous years. The reactivity of chlorine trifluoride makes it an...

Continue Reading
Ryde Group's Public Offering: Key Insights and Developments

Updated Category News Views 274

Ryde Group Ltd (NYSE American: RYDE) made waves in the market with its public offering valued at approximately $4.5 million. The offering encompassed 5.3 million units, each comprising one Class A Ordinary Share plus a warrant that can be exercised into an additional Ordinary Share at $0.85. With warrants exercisable immediately and valid for five years, traders keen on...

Continue Reading
Citi's Optimistic Forecast for Enel Stock Amid Renewables Growth

Updated Category News Views 145

Citi's Optimistic Outlook on Enel Recently, Citi reaffirmed its strong Buy rating on Enel (BIT: ENEI) SpA stock, maintaining a price target of EUR7.40. This renewed confidence comes ahead of the company's anticipated third-quarter earnings announcement slated for early November. Analysts at Citi predict that Enel is poised to deliver robust financial results, prompting...

Continue Reading